In the past 52-week period, shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) have moved within the range of $39.24 to $72.73. On the stock’s most recent trading day, the company’s shares ended the regular session at $72.54, which is 0.26% lower than its 52-week high.
Agios Pharmaceuticals, Inc. (AGIO) has demonstrated a 20-day simple moving average (SMA) of 25.20%, and a 50-day SMA of 20.23%. This public company’s current market capitalization stands at $3.47 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Agios Pharmaceuticals, Inc. (AGIO) is Outperform.
When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Agios Pharmaceuticals, Inc. (AGIO) delivered a 16.29% surprise with its net revenue. Sales reached $0.01 billion during the three-month period, compared to the average analyst estimate of $0.01 billion.
Meanwhile, during the same quarter Agios Pharmaceuticals, Inc. (AGIO) delivered a -11.36% earnings surprise. Net earnings for the quarter were posted at -$1.59 per share, whereas Wall Street had forecast -$1.79 per share.Ownership at Agios Pharmaceuticals, Inc. (AGIO), According to Most Recent SEC Filings
A public company’s latest 13F filings tell investors important details about institutional ownership. Agios Pharmaceuticals, Inc. (AGIO) has 0 billion shares outstanding currently, 94.58% of which belong to institutional investors. Those institutional holdings amount to $3.11 billion.
Additionally, according to the most recent 13F filing from Agios Pharmaceuticals, Inc. (AGIO), there were 30 new positions totaling 1,561,553 shares of the company’s stock. There were 24 sold out positions, on the other hand, totaling 1,503,424 shares.Short, Medium and Long Term Indicators
Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Agios Pharmaceuticals, Inc. (AGIO) has had a 20-day average volume of 461,555 shares, with an average of 60% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 398,264 shares, with an average of 50% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 394,153 shares with 33% of long-term indicators pointing to Buy.